Home › SEC Filings › SC 13D Beneficial Ownership
SC 13D Beneficial Ownership
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| GETY | SC 13D/A | bearish | 7/10 | Getty Investments LLC (the Getty family group) filed this SC 13D/A to disclose a restructuring support agreement (RSA) e | Oct 13, 2026 |
| BBCI | SC 13D | neutral | 3/10 | Loo See Yuen, CEO and director of Bradbury Capital Inc., filed a Schedule 13D disclosing beneficial ownership of 14,725, | Oct 13, 2026 |
| BRAG | SC 13D/A | neutral | 3/10 | Doug Fallon and affiliated entities filed an amended Schedule 13D disclosing that their aggregate beneficial ownership i | Oct 13, 2026 |
| PED | SC 13D/A | bullish | 5/10 | Dr. Simon G. Kukes and his trust (SGK 2018 Revocable Trust) filed Amendment No. 15 to their Schedule 13D, reporting the | Oct 13, 2026 |
| GDTC | SC 13D/A | neutral | 3/10 | Chairman Choo Chee Kong filed an amended Schedule 13D disclosing open-market purchases of 62,000 ordinary shares of Cyto | Oct 13, 2026 |
| SYRE | SC 13D/A | neutral | 3/10 | Fairmount Funds Management LLC filed Amendment No. 8 to its Schedule 13D on Spyre Therapeutics, reporting no change in b | Oct 9, 2026 |
| WAI | SC 13D | neutral | 3/10 | CEO and Chairman Ruilin Xu filed a Schedule 13D disclosing 90.71% voting power in Nexpu Ltd. (WAI) as of October 8, 2026 | Oct 9, 2026 |
| NCMI | SC 13D | neutral | 4/10 | Blantyre Capital II Limited filed a Schedule 13D disclosing beneficial ownership of 27,141,507 shares of National CineMe | Oct 9, 2026 |
| WBUY | SC 13D | neutral | 5/10 | Zheng Mingjie, a Chinese individual investor, filed a Schedule 13D disclosing beneficial ownership of 1,139,472 Class A | Oct 9, 2026 |
| VDTA | SC 13D | neutral | 3/10 | Jesse Nickel, an insider (Head of Business Development) of Vertical Data Inc., filed a Schedule 13D disclosing beneficia | Oct 9, 2026 |
| VDTA | SC 13D | neutral | 3/10 | Christopher Creatura, the Chief Credit Officer of Vertical Data Inc., filed a Schedule 13D disclosing beneficial ownersh | Oct 9, 2026 |
| GWLL | SC 13D | neutral | 4/10 | Ming Zhou filed a Schedule 13D disclosing beneficial ownership of 20,000,000 shares (20.2%) of Goldenwell Biotech, acqui | Oct 9, 2026 |
| KARX | SC 13D/A | bearish | 5/10 | Morsevo Trade, Inc. filed Amendment No. 3 to its Schedule 13D on Karbon-X Corp., reporting a reduction in beneficial own | Oct 9, 2026 |
| OMTK | SC 13D | bearish | 8/10 | Hard Rock Holdco LLC and its manager Kevin Jay Hayes Jr. have filed a Schedule 13D disclosing beneficial ownership of 85 | Oct 9, 2026 |
| GGR | SC 13D/A | neutral | 6/10 | Gold Sino Assets Ltd and affiliates filed Amendment No. 4 to their Schedule 13D, reporting a significant increase in ben | Oct 9, 2026 |
| MLCO | SC 13D/A | neutral | 3/10 | Melco International Development Ltd and related parties filed Amendment No. 10 to their Schedule 13D, reporting a change | Oct 9, 2026 |
| PUSA | SC 13D | neutral | 5/10 | Andrew Fox, the CEO and Chairman of Powerus Corp (f/k/a Aureus Greenway Holdings Inc.), filed a Schedule 13D disclosing | Oct 8, 2026 |
| GOSS | SC 13D/A | bearish | 5/10 | D. E. Shaw filed Amendment No. 5 to its Schedule 13D for Gossamer Bio, primarily to correct an understatement of voting | Oct 8, 2026 |
| SDRL | SC 13D/A | bearish | 6/10 | Elliott Investment Management filed Amendment No. 9 to its Schedule 13D on Seadrill Ltd, reporting a reduction in its be | Oct 8, 2026 |
| AVBP | SC 13D/A | bearish | 5/10 | OrbiMed Advisors filed Amendment No. 2 to its Schedule 13D for ArriVent BioPharma (AVBP), reporting a reduction in benef | Oct 8, 2026 |
| GAP | SC 13D/A | neutral | 4/10 | William S. Fisher, a director and 13.5% holder of Gap Inc., filed an amended Schedule 13D reporting a net reduction in h | Oct 8, 2026 |
| CBL | SC 13D/A | neutral | 4/10 | Canyon Capital Advisors LLC filed Amendment No. 6 to its Schedule 13D, reporting a sale of 1,307,500 shares of CBL commo | Oct 8, 2026 |
| WKEY | SC 13D/A | neutral | 4/10 | Carlos Moreira, Chairman and CEO of WISeQey Corp. (formerly WISeKey International Holding AG), filed Amendment No. 4 to | Oct 8, 2026 |
| SAIQ | SC 13D | neutral | 4/10 | WISeQey Corp., SEALSQ Corp., and Carlos Moreira filed a Schedule 13D disclosing aggregate beneficial ownership of 26,405 | Oct 8, 2026 |
| HESM | SC 13D/A | bullish | 7/10 | Hess Investments North Dakota LLC (an indirect Chevron subsidiary) filed Amendment No. 27 to its Schedule 13D, disclosin | Oct 8, 2026 |
| ANGH | SC 13D/A | neutral | 5/10 | Skydance Corp has filed Amendment No. 4 to its Schedule 13D for Anghami Inc, reporting that it became the ultimate benef | Oct 8, 2026 |
| WKEY | SC 13D/A | neutral | 4/10 | Director Peter Ward filed this Schedule 13D/A to report changes in his beneficial ownership of WISeQey Corp. (formerly W | Oct 8, 2026 |
| INSW | SC 13D/A | neutral | 4/10 | An amendment to Schedule 13D was filed for International Seaways, Inc. (INSW), but the actual filing content was unavail | Oct 8, 2026 |
| ESE | SC 13D | neutral | 6/10 | TBG AG, a Swiss investment firm, filed a Schedule 13D after receiving 5,100,000 shares of ESCO Technologies (ESE) as par | Oct 8, 2026 |
| BHR | SC 13D/A | neutral | 5/10 | Al Shams Investments has settled its proxy fight with Braemar Hotels & Resorts, withdrawing its director nomination slat | Oct 8, 2026 |